Research Article
Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease
Table 1
General characteristics of controls and Fabry patients.
| Variables | Controls (: 20) | Fabry (: 44) | value |
| Age (years) | 30 (20–48) | 31 (11–86) | 0.92 | Gender (males) | 10 (50%) | 17 (38.6%) | 0.59 | Hypertension | 0 (0%) | 6 (14%) | 0.001 | eGFR (ml/min/1.73 m2) | 110 (86–141) | 120.5 (60–165) | 0.10 | UPCR (g/g) | 0.03 (0.02–0.27) | 0.06 (0.02–5.68) | 0.01 | Urinary uPAR+ podocytes/creatininuria (cells/g) | 0 (0–73.99) | 28.88 (0–284.46) | <0.001 |
|
|